INM

Inmed Pharmaceuticals Inc

• TipRanks·4d ago

  InMed Pharmaceuticals Announces ATM Offering Prospectus Filing

• Reuters·5d ago

  InMed Pharmaceuticals files prospectus supplement for at-the-market common share offering

• TipRanks·03/30 22:58

  InMed Pharmaceuticals Faces Nasdaq Minimum Bid Price Noncompliance

• TipRanks·03/30 15:22

  InMed receives Nasdaq notification regarding minimum bid price compliance

• TipRanks·03/27 22:50

  InMed warned by Nasdaq over minimum bid price non-compliance

• Seeking Alpha·03/27 21:12

  InMed Pharma gets Nasdaq non-compliance notice

• Reuters·03/27 21:05

  InMed Pharmaceuticals drops on Nasdaq notice; bid price stays below $1.00 for 30 straight sessions

• Newsfile·03/27 21:05

  InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

• TipRanks·03/23 11:58

  InMed Reports Positive Preclinical Data for Alzheimer’s Candidate

• TipRanks·03/23 11:50

  InMed Pharmaceuticals announces preclinical data on effects of INM-901

• Benzinga·03/23 11:41

  InMed Reports Preclinical Data Showing Reduced Brain Inflammation in Alzheimer's Models

• Reuters·03/23 11:34

  INMED PHARMACEUTICALS INC - PLANS PRE-IND MEETING WITH U.S. FDA FOR INM-901 IN Q3 2026 - SEC FILING

• Reuters·03/23 11:32

  InMed reports INM-901 reduces IL-6 and IL-8 in human Alzheimer’s brain organoid models

• Newsfile·03/23 11:30

  InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

• Benzinga·03/20 21:12

  InMed Pharmaceuticals Files Prospectus To Offer Up To $50M In Securities